Tinctures, gummies, and chocolates come with absorption stories: a tincture “absorbs better” or “skips digestion”; an edible is “gentler” or “longer.” These are claims about bioavailability and pharmacokinetics — how much compound reaches circulation and how fast. [1] Peer-reviewed Psychedelics doi:10.1124/pr.115.011478 Some are plausible. None is a demonstrated microdose benefit. Plausible pharmacokinetics is not efficacy, and the sub-perceptual effect these formats would supposedly improve has not been established. [2] Systematic review Is microdosing a placebo? A rapid review of low-dose LSD and psilocybin research doi:10.1177/02698811241254831 No preparation instructions appear here.
Education-only orientation. This is not medical, dosing, sourcing, preparation, or legal advice. Decisions about any substance belong with a qualified clinician.
What this page does and does not contain. It examines formats as a pharmacology and measurement topic and does not recommend, rank, or instruct on any format. It contains no preparation recipes or steps, no doses, weights, ratios, milligrams, gram amounts, scales, or increments, no format-sequencing-by-cycle, no product, brand, or store recommendations, no “best format” verdict, and no potency- or onset-boosting claim stated as fact. Every such claim from buying guides is examined here as a claim, not reproduced as instruction.
What these formats actually claim
The marketing register is consistent: a liquid is absorbed more efficiently; a sublingual route bypasses the gut; an edible smooths or extends the curve. Each is a pharmacokinetic assertion about the fraction absorbed and the timing. Some have surface plausibility from general pharmacology. Plausibility is the fourth distinction’s trap: a believable mechanism is routinely presented as if it were a measured result. [3] Peer-reviewed Microdosing psychedelics: More questions than answers? An overview and suggestions for future research doi:10.1177/0269881119857204
| Claim | What kind of claim it is | Honest status |
|---|---|---|
| ”Tincture absorbs better” | Bioavailability | Possibly true as pharmacokinetics; unmeasured as microdose outcome |
| ”Skips digestion / sublingual is faster” | Pharmacokinetics | Plausible for some routes; not shown to change sub-perceptual results |
| ”Edible is gentler or longer” | Pharmacokinetics | Describes a curve, not a benefit |
| ”Better absorption means it works better” | Efficacy | Unsupported leap from plausibility to result |
Why plausible absorption is not a benefit
Even granting that a format raises bioavailability, the chain to “works better” has missing links. A higher absorbed fraction at a sub-perceptual dose may produce no perceptible change; any change a person reports is consistent with expectation; and a report is not a controlled outcome. [2] Systematic review Is microdosing a placebo? A rapid review of low-dose LSD and psilocybin research doi:10.1177/02698811241254831 Because no microdose effect has been demonstrated, there is no established result for better absorption to enlarge. [4] Systematic review The emerging science of microdosing: A systematic review of research on low dose psychedelics (1955-2021) and recommendations for the field doi:10.1016/j.neubiorev.2022.104706
The supplement framing
Edibles and tinctures are often sold in the register of a dietary supplement — wellness language, structure-function phrasing, and implied benefit without the evidentiary burden a medicine carries. That framing inherits the same weakness: it borrows the appearance of health benefit while sidestepping the controlled comparison that would establish one. [3] Peer-reviewed Microdosing psychedelics: More questions than answers? An overview and suggestions for future research doi:10.1177/0269881119857204 Recognizing the register is part of reading the claim.
The honest position
These formats may differ in convenience, palatability, and stability — and possibly in pharmacokinetics. Stability and degradation are covered as a research topic in Mushroom Intelligence. What none of them does is convert a plausible absorption story into a demonstrated sub-perceptual benefit. The right verb for every absorption claim here is “may affect the pharmacokinetics,” never “works better.”
- Bioavailability is pharmacokinetics
- Absorption claims describe a fraction reaching circulation, not a benefit. [1] Peer-reviewed Psychedelics doi:10.1124/pr.115.011478
- Plausibility ≠ efficacy
- A believable mechanism is not a measured outcome. [2] Systematic review Is microdosing a placebo? A rapid review of low-dose LSD and psilocybin research doi:10.1177/02698811241254831
- No baseline to improve
- No demonstrated microdose effect exists for better absorption to enlarge. [4] Systematic review The emerging science of microdosing: A systematic review of research on low dose psychedelics (1955-2021) and recommendations for the field doi:10.1016/j.neubiorev.2022.104706
- Supplement register
- Wellness framing borrows the look of benefit without the evidentiary burden. [3] Peer-reviewed Microdosing psychedelics: More questions than answers? An overview and suggestions for future research doi:10.1177/0269881119857204
Frequently asked questions
Do tinctures really “absorb better” or “skip digestion”?
Some routes do differ in how much compound reaches circulation and how fast, so the claim can be plausible as pharmacokinetics. [1] Peer-reviewed Psychedelics doi:10.1124/pr.115.011478 But plausible absorption is not a demonstrated benefit. A higher absorbed fraction at a sub-perceptual dose may produce no measurable change, and no controlled study shows tinctures improve microdose outcomes.
Are gummies or chocolates gentler or longer-lasting?
Those describe the shape of an absorption curve, not an outcome. An edible may change timing through variable digestion, but that is a pharmacokinetic difference. It is not evidence that the edible produces a benefit, because the sub-perceptual effect it would supposedly smooth has not been established. [2] Systematic review Is microdosing a placebo? A rapid review of low-dose LSD and psilocybin research doi:10.1177/02698811241254831
Why treat these like supplements?
Because they are often sold that way — with wellness language and implied benefit but without the controlled evidence a medicine must show. [3] Peer-reviewed Microdosing psychedelics: More questions than answers? An overview and suggestions for future research doi:10.1177/0269881119857204 That dietary-supplement register borrows the appearance of a health benefit while avoiding the comparison that would establish one. Naming the register helps read the claim accurately.
Will this page explain how to make a tincture or edible?
No. The site examines extraction and edible claims as claims and provides no method, solvent, ratios, or preparation steps. Stability and degradation are discussed as a research topic in Mushroom Intelligence, not as a how-to here. [4] Systematic review The emerging science of microdosing: A systematic review of research on low dose psychedelics (1955-2021) and recommendations for the field doi:10.1016/j.neubiorev.2022.104706